Skip to content

Comparison of the influence nigella sativa with mefenamic acid on primary dysmenorrhea

Comparison of the influence nigella sativa with mefenamic acid on primary dysmenorrhea

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014040117111N1
Enrollment
70
Registered
2015-01-26
Start date
2014-11-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhoea. Primary dysmenorrhoea

Interventions

Intervention 1: one intervention group: consumption of oral nigella sativa 3 grams daily (two capsules of 500 mg every 8 hours) during the first three days of menstruation. Intervention 2: Two interve
Treatment - Drugs
one intervention group: consumption of oral nigella sativa 3 grams daily (two capsules of 500 mg every 8 hours) during the first three days of menstruation
Two intervention groups: consumption Mefenamic Acid 250 mg (two 500 mg capsules with 125 milligrams of active ingredient Mefenamic acid every 8 hours during the first three days of menstruation

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age range between 30-18 years of being single and female students studying in Iran Mashhad university dormitories having regular menstrual periods of moderate to severe primary dysmenorrhea grade based on a visual scale Exclusion criteria: history abdominal or pelvic surgery, history of sexual problems of mishaps during study coagulation disorders or abnormal uterine pelvic ultrasound consumption hormonal drugs (eg contraception), NSAIDs, opioids or any ban the sensitivity to drugs obesity (BMI greater than 30)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Intensity and duration of menstrual pain. Timepoint: 1) two cycles before the intervention, 2) the first and second cycles of the intervention. Method of measurement: Visual analog scale and the scale Cox.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh mohanazadeh falaheieh

Mashhad University of Medical Sciences

mohanazadehf911@ mums.ac.ir ? mohana6492@gmail.com+98 51 3852 8512

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026